Parallel Advisors »

Cerevel Therapeutics Hldng I shares owned by Parallel Advisors

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $169 4 42.25
2023-12-31 $170 4 42.50
2022-12-31 $95 3 31.67
2021-12-31 $0 9 0.00

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Guggenheim Etf Trust S&p 500 Equal Weight Etf (RSP)
Ishares Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)

View all positions for Parallel Advisors

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Alpine Associates Management
Paradigm Biocapital Advisors
Balyasny Asset Management
Citigroup
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company

View all funds holding Cerevel Therapeutics Hldng I